Correlation Between Longeveron LLC and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Longeveron LLC and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Longeveron LLC and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Longeveron LLC and Seres Therapeutics, you can compare the effects of market volatilities on Longeveron LLC and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Longeveron LLC with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Longeveron LLC and Seres Therapeutics.
Diversification Opportunities for Longeveron LLC and Seres Therapeutics
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Longeveron and Seres is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Longeveron LLC and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Longeveron LLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Longeveron LLC are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Longeveron LLC i.e., Longeveron LLC and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Longeveron LLC and Seres Therapeutics
Given the investment horizon of 90 days Longeveron LLC is expected to generate 9.33 times less return on investment than Seres Therapeutics. But when comparing it to its historical volatility, Longeveron LLC is 1.78 times less risky than Seres Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Seres Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 78.00 in Seres Therapeutics on September 3, 2024 and sell it today you would earn a total of 20.00 from holding Seres Therapeutics or generate 25.64% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Longeveron LLC vs. Seres Therapeutics
Performance |
Timeline |
Longeveron LLC |
Seres Therapeutics |
Longeveron LLC and Seres Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Longeveron LLC and Seres Therapeutics
The main advantage of trading using opposite Longeveron LLC and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Longeveron LLC position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.Longeveron LLC vs. DiaMedica Therapeutics | Longeveron LLC vs. Lyra Therapeutics | Longeveron LLC vs. Centessa Pharmaceuticals PLC |
Seres Therapeutics vs. DiaMedica Therapeutics | Seres Therapeutics vs. Lyra Therapeutics | Seres Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |